Linked Life Data

3495483

Source:http://linkedlifedata.com/resource/pubmed/id/3495483

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3495483rdf:typepubmed:Citationlld:pubmed
pubmed-article:3495483lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3495483lifeskim:mentionsumls-concept:C0205474lld:lifeskim
pubmed-article:3495483lifeskim:mentionsumls-concept:C0682526lld:lifeskim
pubmed-article:3495483lifeskim:mentionsumls-concept:C1327616lld:lifeskim
pubmed-article:3495483lifeskim:mentionsumls-concept:C0123245lld:lifeskim
pubmed-article:3495483lifeskim:mentionsumls-concept:C0728938lld:lifeskim
pubmed-article:3495483lifeskim:mentionsumls-concept:C1998793lld:lifeskim
pubmed-article:3495483lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:3495483pubmed:issue4lld:pubmed
pubmed-article:3495483pubmed:dateCreated1987-7-9lld:pubmed
pubmed-article:3495483pubmed:abstractTextIgE-binding factors (IgE-BFs) were purified from the culture supernatant of RPMI-8866 cells, a human lymphoblastoid B-cell line expressing IgE receptors. The material, purified by affinity-chromatography on immunoadsorbents coupled to IgE or to monoclonal antibody against IgE receptor, was comprised of two major components with apparent molecular weight (MW) of 25,000-27,000 and 12,000, as determined by SDS-PAGE and silver staining. Only the 25,000-27,000 MW molecules were identified as IgE-BFs, as demonstrated by their reactivity with MabER in the Western blot and the immunoprecipitation assays, and their ability to inhibit rosette formation of U937 cells with IgE- but not with IgG-coated erythrocytes. IgE-BFs were purified to homogeneity by combining affinity-chromatography and either DEAE-ion exchange or reverse-phase chromatography on an HPLC system. Chromatofocusing analysis demonstrated the microheterogeneity of IgE-BFs that were comprised of molecules with isoelectric points ranging from 5.0 to 4.4. IgE-BFs were sensitive to treatment with O-glycosidase but not with N-glycanase. These molecules were resistant to heat and to pH ranging from 2 to 9; their immunoreactivity was lost after treatment with trypsin and pepsin. Papain digestion of purified IgE-BFs generated 14,000-16,000 MW molecules that were still binding to IgE and to MabER.lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:languageenglld:pubmed
pubmed-article:3495483pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:citationSubsetIMlld:pubmed
pubmed-article:3495483pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3495483pubmed:statusMEDLINElld:pubmed
pubmed-article:3495483pubmed:monthAprlld:pubmed
pubmed-article:3495483pubmed:issn0019-2805lld:pubmed
pubmed-article:3495483pubmed:authorpubmed-author:NakajimaTTlld:pubmed
pubmed-article:3495483pubmed:authorpubmed-author:DelespesseGGlld:pubmed
pubmed-article:3495483pubmed:authorpubmed-author:GREEPR WRWlld:pubmed
pubmed-article:3495483pubmed:authorpubmed-author:SarfatiMMlld:pubmed
pubmed-article:3495483pubmed:authorpubmed-author:KilccherrEElld:pubmed
pubmed-article:3495483pubmed:issnTypePrintlld:pubmed
pubmed-article:3495483pubmed:volume60lld:pubmed
pubmed-article:3495483pubmed:ownerNLMlld:pubmed
pubmed-article:3495483pubmed:authorsCompleteYlld:pubmed
pubmed-article:3495483pubmed:pagination539-45lld:pubmed
pubmed-article:3495483pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:3495483pubmed:meshHeadingpubmed-meshheading:3495483-...lld:pubmed
pubmed-article:3495483pubmed:meshHeadingpubmed-meshheading:3495483-...lld:pubmed
pubmed-article:3495483pubmed:meshHeadingpubmed-meshheading:3495483-...lld:pubmed
pubmed-article:3495483pubmed:meshHeadingpubmed-meshheading:3495483-...lld:pubmed
pubmed-article:3495483pubmed:meshHeadingpubmed-meshheading:3495483-...lld:pubmed
pubmed-article:3495483pubmed:meshHeadingpubmed-meshheading:3495483-...lld:pubmed
pubmed-article:3495483pubmed:meshHeadingpubmed-meshheading:3495483-...lld:pubmed
pubmed-article:3495483pubmed:meshHeadingpubmed-meshheading:3495483-...lld:pubmed
pubmed-article:3495483pubmed:meshHeadingpubmed-meshheading:3495483-...lld:pubmed
pubmed-article:3495483pubmed:meshHeadingpubmed-meshheading:3495483-...lld:pubmed
pubmed-article:3495483pubmed:meshHeadingpubmed-meshheading:3495483-...lld:pubmed
pubmed-article:3495483pubmed:meshHeadingpubmed-meshheading:3495483-...lld:pubmed
pubmed-article:3495483pubmed:year1987lld:pubmed
pubmed-article:3495483pubmed:articleTitlePurification and partial biochemical characterization of IgE-binding factors secreted by a human B lymphoblastoid cell line.lld:pubmed
pubmed-article:3495483pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3495483pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3495483lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3495483lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3495483lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3495483lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3495483lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3495483lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3495483lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3495483lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3495483lld:pubmed